Hyperliquid Strategies, Sonnet Close Business Combination
Hyperliquid Strategies (NASDAQ:PURR) completed a business combination with Sonnet BioTherapeutics (NASDAQ:SONN) and Rorschach I LLC,...
Hyperliquid Strategies (NASDAQ:PURR) completed a business combination with Sonnet BioTherapeutics (NASDAQ:SONN) and Rorschach I LLC,...